MARKET INTRODUCTION
Diabetes monitoring devices are used to monitor the level of glucose into a patient's body. These devices also enable in delivery of insulin into the patient's body.
MARKET DYNAMICS
The factors that drive the Global Diabetes Monitoring Devices market include rise in geriatric population and rise in prevalence of diabetes worldwide. In addition, technological advancements in the field of diabetes devices, and increase in need for faster and safer diagnosis and treatment of diabetes are further expected to boost the market growth. However, inadequate reimbursement may impede the market growth in the review period.
MARKET SCOPE
The "Global Diabetes Monitoring Devices Market analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Diabetes Monitoring Devices Market with detailed market segmentation by product, end-users and geography. The Global Diabetes Monitoring Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Diabetes Monitoring Devices Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Diabetes Monitoring Devices Market is segmented on the basis of product, end-users. On the basis of product, the market is segmented into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is further segmented into testing strips, self-monitoring blood glucose meters, lancets, and continuous blood glucose monitoring devices. The insulin delivery devices is further sub segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. Based on end-users the market is segment into, hospitals, diagnostics, and home settings. ?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Diabetes Monitoring Devices Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Diabetes Monitoring Devices Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Diabetes Monitoring Devices market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diabetes Monitoring Devices Market in these regions.
MARKET PLAYERS
The report covers key developments in the Diabetes Monitoring Devices Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Diabetes Monitoring Devices Market are anticipated to lucrative growth opportunities in the future with the rising demand for Diabetes Monitoring Devices Market in the global market. Below mentioned is the list of few companies engaged in the Diabetes Monitoring Devices Market.
The report also includes the profiles of key Diabetes Monitoring Devices Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- ACON Laboratories, Inc.
- Ascensia Diabetes Care Holdings AG
- Becton, Dickinson and Company
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Medtronic plc.
- Novo Nordisk A/S
- Terumo Corporation.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Diabetes Monitoring Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Visualization and 3D Rendering Software Market
- 3D Audio Market
- Smart Parking Market
- Biopharmaceutical Contract Manufacturing Market
- Saudi Arabia Drywall Panels Market
- Industrial Inkjet Printers Market
- Single Pair Ethernet Market
- Non-Emergency Medical Transportation Market
- Battery Testing Equipment Market
- Europe Surety Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Abbott Laboratories
2. ACON Laboratories, Inc.
3. Ascensia Diabetes Care Holdings AG
4. Becton, Dickinson and Company
5. Dexcom, Inc.
6. F. Hoffmann-La Roche Ltd
7. Johnson & Johnson
8. Medtronic plc.
9. Novo Nordisk A/S
10. Terumo Corporation
1. Abbott Laboratories
2. ACON Laboratories, Inc.
3. Ascensia Diabetes Care Holdings AG
4. Becton, Dickinson and Company
5. Dexcom, Inc.
6. F. Hoffmann-La Roche Ltd
7. Johnson & Johnson
8. Medtronic plc.
9. Novo Nordisk A/S
10. Terumo Corporation